(0.11%) 5 254.35 points
(0.12%) 39 807 points
(-0.12%) 16 379 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(-0.05%) $0.926
(-0.07%) $10.83
(-0.18%) $0.791
(-0.09%) $92.49
@ $22.58
Issued: 14 Feb 2024 @ 14:40
Return: 9.32%
Previous signal: Feb 14 - 10:32
Previous signal:
Return: 6.29 %
Live Chart Being Loaded With Signals
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system...
Stats | |
---|---|
Today's Volume | 1.22M |
Average Volume | 688 249 |
Market Cap | 1.05B |
EPS | $0 ( 2024-03-21 ) |
Next earnings date | ( $0 ) 2024-05-03 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -13.71 |
ATR14 | $0.0610 (0.25%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-20 | Horn Kinney | Buy | 300 000 | Stock option (right to buy) |
2024-02-12 | Horn Kinney | Buy | 0 | |
2024-01-31 | Rosett Max | Buy | 175 000 | Stock option (right to buy) |
2024-01-31 | Stoneman Sandra G. | Buy | 200 000 | Stock option (right to buy) |
2024-01-02 | Lapetina Bob | Sell | 0 | Common Stock |
INSIDER POWER |
---|
-15.67 |
Last 93 transactions |
Buy: 3 618 517 | Sell: 4 251 388 |
Volume Correlation
Immunome, Inc. Correlation
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Immunome, Inc. Correlation - Currency/Commodity
Immunome, Inc. Financials
Annual | 2022 |
Revenue: | $0 |
Gross Profit: | $-631 000 (0.00 %) |
EPS: | $-3.09 |
Q3 | 2023 |
Revenue: | $3.57M |
Gross Profit: | $3.40M (95.34 %) |
EPS: | $-0.360 |
Q2 | 2023 |
Revenue: | $4.26M |
Gross Profit: | $4.11M (96.32 %) |
EPS: | $-0.460 |
Q1 | 2023 |
Revenue: | $2.36M |
Gross Profit: | $2.22M (93.74 %) |
EPS: | $-0.330 |
Financial Reports:
No articles found.
Immunome, Inc.
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2 infections and COVID-19. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators